高级搜索
顺铂的时辰化疗[J]. 肿瘤防治研究, 2007, 34(09): 714-715. DOI: 10.3971/j.issn.1000-8578.3188
引用本文: 顺铂的时辰化疗[J]. 肿瘤防治研究, 2007, 34(09): 714-715. DOI: 10.3971/j.issn.1000-8578.3188
Chronomodulated Infusion of Cisplatin[J]. Cancer Research on Prevention and Treatment, 2007, 34(09): 714-715. DOI: 10.3971/j.issn.1000-8578.3188
Citation: Chronomodulated Infusion of Cisplatin[J]. Cancer Research on Prevention and Treatment, 2007, 34(09): 714-715. DOI: 10.3971/j.issn.1000-8578.3188

顺铂的时辰化疗

Chronomodulated Infusion of Cisplatin

  • 摘要: 目的 观察按时辰给药能否减轻顺铂(cisplatin,PDD)的毒副反应。方法 自2004年4月~2006年3月以时辰给药方式治疗29例肿瘤患者(A组),化疗方案主要有NVB/PDD;PDD/CF/5-Fu;Taxotere/PDD。药物输注采用法国Aguettant公司生产的“Melodie”4通道程控输液泵,以正弦曲线方式给药。PDD20mg/(m^2.d),自10∶00~22∶00,峰值在16∶00,d1~4;同期30例含PDD方案化疗的患者为对照(B组),对照组PDD25mg/(m2.d),自09∶00~10∶00,d1~3,常规输注。两组病例均同样采用5-HT3受体拮抗剂+地塞米松止吐,同样水化、利尿处理。结果 A组共完成72个周期的化疗,平均每个病例完成2.48个周期。两组(A∶B)毒副反应的发生率分别为:急性呕吐13.79%∶53.33%,P〈0.001;延迟呕吐3.45%∶43.33%,P〈0.001;恶心31.03%∶63.33%,P〈0.05。血液学毒性和肝肾毒性两组无差异。结论 时辰给药在控制PDD的胃肠道反应方面具有显著性优势,从而在化疗期间带来更好的生活质量,值得临床进一步推广使用。

     

    Abstract: Objective To investigate whether chronotherapy can reduce the toxicities caused by cisplatin. Methods From April 2004 to March 2006,29 cases received cisplatin-based regimens by multichannel, programmable pumps as group A. Cisplatin was given in 20 mg/(m2·d), from 10∶00 to 22∶00,peak at 16∶00,d1~4; The other 30 cases received same regimens as group B, Cisplatin was given in 25 mg/(m2·d), from 09∶00 to 10∶00, d1~3. Both groups received the same treatment to prevent the toxities caused by cisplatin. Results 2...

     

/

返回文章
返回